Hypercortisolism Is More Common Than You Think-Here's How to Find It

Overview

Journal Fed Pract

Date 2025 Jan 22

PMID 39839060

Authors

Pamela Kushner

David R Brown

Robert S Busch

Affiliations

Soon will be listed here.

References

Lindholm J, Juul S, Jorgensen J, Astrup J, Bjerre P, Feldt-Rasmussen U . Incidence and late prognosis of cushing's syndrome: a population-based study. J Clin Endocrinol Metab. 2001; 86(1):117-23. DOI: 10.1210/jcem.86.1.7093. View

Trifanescu R, Carsote M, Caragheorgheopol A, Hortopan D, Dumitrascu A, Dobrescu M . Screening for secondary endocrine hypertension in young patients. Maedica (Bucur). 2013; 8(2):108-15. PMC: 3865118. View

Scoffings K, Morris D, Pullen A, Temple S, Trigell A, Gurnell M . Recognising and diagnosing Cushing's syndrome in primary care: challenging but not impossible. Br J Gen Pract. 2022; 72(721):399-401. PMC: 9343052. DOI: 10.3399/bjgp22X720449. View

Braun L, Vogel F, Zopp S, Seiter T, Rubinstein G, Berr C . Whom Should We Screen for Cushing Syndrome? The Endocrine Society Practice Guideline Recommendations 2008 Revisited. J Clin Endocrinol Metab. 2022; 107(9):e3723-e3730. PMC: 9387700. DOI: 10.1210/clinem/dgac379. View

Kelsall A, Newell-Price J . Cushing's disease-from Minnie G to key issues in the early 21st century. Lancet Diabetes Endocrinol. 2019; 7(12):959-964. DOI: 10.1016/S2213-8587(19)30343-2. View

Farinelli D, Oliveira K, Hayashi L, Kater C . Overnight 1-mg Dexamethasone Suppression Test for Screening Cushing Syndrome and Mild Autonomous Cortisol Secretion (MACS): What Happens when Serum Dexamethasone Is Below Cutoff? How Frequent Is it?. Endocr Pract. 2023; 29(12):986-993. DOI: 10.1016/j.eprac.2023.09.007. View

Araujo-Castro M, Pascual-Corrales E, Lamas C . Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity. Ann Endocrinol (Paris). 2023; 84(2):272-284. DOI: 10.1016/j.ando.2023.01.005. View

Yorke E, Atiase Y, Akpalu J, Sarfo-Kantanka O . Screening for Cushing Syndrome at the Primary Care Level: What Every General Practitioner Must Know. Int J Endocrinol. 2017; 2017:1547358. PMC: 5551520. DOI: 10.1155/2017/1547358. View

Limumpornpetch P, Morgan A, Tiganescu A, Baxter P, Nyaga V, Pujades-Rodriguez M . The Effect of Endogenous Cushing Syndrome on All-cause and Cause-specific Mortality. J Clin Endocrinol Metab. 2022; 107(8):2377-2388. PMC: 9282270. DOI: 10.1210/clinem/dgac265. View

10.

Dekkers O, Horvath-Puho E, Jorgensen J, Cannegieter S, Ehrenstein V, Vandenbroucke J . Multisystem morbidity and mortality in Cushing's syndrome: a cohort study. J Clin Endocrinol Metab. 2013; 98(6):2277-84. DOI: 10.1210/jc.2012-3582. View

11.

Reincke M, Fleseriu M . Cushing Syndrome: A Review. JAMA. 2023; 330(2):170-181. DOI: 10.1001/jama.2023.11305. View

12.

Goder N, Gerstenhaber F, Gal Oz A, Stavi D, Angel Y, Nini A . Cortisol Levels During First Admission Day Are Associated With Clinical Outcomes in Surgical Critically Ill Patients. Crit Care Explor. 2024; 6(5):e1086. PMC: 11081545. DOI: 10.1097/CCE.0000000000001086. View

13.

Chiodini I, Mascia M, Muscarella S, Battista C, Minisola S, Arosio M . Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann Intern Med. 2007; 147(8):541-8. DOI: 10.7326/0003-4819-147-8-200710160-00006. View

14.

Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V . Occult Cushing's syndrome in type-2 diabetes. J Clin Endocrinol Metab. 2003; 88(12):5808-13. DOI: 10.1210/jc.2003-030254. View

15.

Clayton R, Raskauskiene D, Reulen R, Jones P . Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J Clin Endocrinol Metab. 2011; 96(3):632-42. DOI: 10.1210/jc.2010-1942. View

16.

Nieman L, Biller B, Findling J, Newell-Price J, Savage M, Stewart P . The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008; 93(5):1526-40. PMC: 2386281. DOI: 10.1210/jc.2008-0125. View

17.

DeFronzo R, Auchus R, Bancos I, Blonde L, Busch R, Buse J . Study protocol for a prospective, multicentre study of hypercortisolism in patients with difficult-to-control type 2 diabetes (CATALYST): prevalence and treatment with mifepristone. BMJ Open. 2024; 14(7):e081121. PMC: 11253743. DOI: 10.1136/bmjopen-2023-081121. View

18.

Petersenn S, Newell-Price J, Findling J, Gu F, Maldonado M, Sen K . High variability in baseline urinary free cortisol values in patients with Cushing's disease. Clin Endocrinol (Oxf). 2013; 80(2):261-9. PMC: 4231220. DOI: 10.1111/cen.12259. View

19.

van Hulsteijn L, Pasquali R, Casanueva F, Haluzik M, Ledoux S, Monteiro M . Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis. Eur J Endocrinol. 2019; 182(1):11-21. DOI: 10.1530/EJE-19-0666. View

20.

Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein S . The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev. 2004; 25(2):309-40. DOI: 10.1210/er.2002-0031. View